NEW Dividiend Portfolio Tracker (DRIPTracker) is Now Live!
Track your stocks, dividends, monitor DRIP shares, and project your passive income.
Start Free »

Agilent Technologies, Inc. A | NYSE

$137.45 $0.00 | 0.00%

Next Earnings: Jul 31, 2026

Company Overview:

Market Cap: $0
Trailing PE: 0x
52-Week Range: $108.35 - $160.27

10 Year A Performance Metrics:

Total Return (with DRIP): 210.4% (11.99% CAGR)
Total Return (no DRIP): 203.5% (11.74% CAGR)
Share Price: 187.1% (11.12% CAGR)
Dividend Increase: 121.7% (8.30% CAGR)
Dividend Yield (FWD): 0.74% ($1.02)
A 10-yr Total Return ($10K invested)
1Y 2Y 5Y 10Y All

A Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
A Dividend CAGR:1Y: 2.82%2Y: 3.95%5Y: 5.62%10Y: 8.29%
Share Price
A Price CAGR:1Y: 19.72%2Y: -1.41%5Y: -2.15%10Y: 11.12%

Unlock All Reports & Research Dividend Stocks.

[lev_ptables no_sale]

A Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend Payout Ratio - A
7-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - A
7-Day FREE Trial Get Full Access Now!

A Earnings, Revenue, Cash & Debt, Shares Outstaning:

A - Revenue
7-Day FREE Trial Get Full Access Now!
A Revenue CAGR:1Y: 10.01%2Y: 8.01%5Y: 3.77%10Y: 6.06%
A - Earnings Per Share (EPS)
7-Day FREE Trial Get Full Access Now!
A EPS CAGR:1Y: 60.00%2Y: 6.90%5Y: 11.38%10Y: 15.67%
A - Net Income
7-Day FREE Trial Get Full Access Now!
A Net Income CAGR:1Y: 57.67%2Y: 4.91%5Y: 9.43%10Y: 14.06%
A - EBITDA
7-Day FREE Trial Get Full Access Now!
A EBITDA CAGR:1Y: 38.12%2Y: 7.09%5Y: 6.21%10Y: 9.65%
A - Free Cash Flow
7-Day FREE Trial Get Full Access Now!
A Free Cash Flow CAGR:1Y: 245.79%2Y: 26.83%5Y: -3.45%10Y: 4.82%
A - Free Cash Flow / Share
7-Day FREE Trial Get Full Access Now!
A Free Cash Flow / Share CAGR:1Y: 248.24%2Y: 29.06%5Y: -2.06%10Y: 6.32%
A - Operating Income
7-Day FREE Trial Get Full Access Now!
A Operating Income CAGR:1Y: 33.00%2Y: 4.84%5Y: 6.74%10Y: 11.78%
A - Gross Profit
7-Day FREE Trial Get Full Access Now!
A Gross Profit CAGR:1Y: 16.51%2Y: 8.57%5Y: 4.31%10Y: 6.65%
A - Shares Outstanding
7-Day FREE Trial Get Full Access Now!
A Shares Outstanding CAGR:1Y: -0.35%2Y: -1.55%5Y: -1.55%10Y: -1.43%
A - Share Buybacks
7-Day FREE Trial Get Full Access Now!
A Share Buybacks CAGR:1Y: -60.61%2Y: -46.84%5Y: -19.73%10Y: -3.62%
A - Stock-Based Comp
7-Day FREE Trial Get Full Access Now!
A Stock-Based Comp CAGR:1Y: 6.67%2Y: 1.60%5Y: 4.24%10Y: 9.43%
A - Expenses
7-Day FREE Trial Get Full Access Now!
A Expenses CAGR:1Y: -18.42%2Y: -4.98%5Y: 24.57%10Y: 14.04%
A - Revenue vs Net Income
7-Day FREE Trial Get Full Access Now!
A - EPS vs FCF / Share
7-Day FREE Trial Get Full Access Now!
A - EPS vs PE Ratio
7-Day FREE Trial Get Full Access Now!
A - FCF vs FCF / Share
7-Day FREE Trial Get Full Access Now!
A - FCF vs Stock Based Comp
7-Day FREE Trial Get Full Access Now!
A - Cash & Debt
7-Day FREE Trial Get Full Access Now!
A - Dividends
7-Day FREE Trial Get Full Access Now!
A Dividend CAGR:1Y: 2.82%2Y: 3.95%5Y: 5.62%10Y: 8.29%
A - Revenue by Segment
7-Day FREE Trial Get Full Access Now!
A Revenue CAGR:1Y: 10.01%2Y: 8.01%5Y: 3.77%10Y: 6.06%
A - Revenue by Region
7-Day FREE Trial Get Full Access Now!
A Revenue CAGR:1Y: 10.01%2Y: 8.01%5Y: 3.77%10Y: 6.06%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

A - REVENUE: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
A Actual Revenue CAGR:1Y: 10.01%2Y: 8.01%5Y: 3.77%10Y: 6.06%
A - EPS: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
A Actual EPS CAGR:1Y: 60.00%2Y: 6.90%5Y: 11.38%10Y: 15.67%
A - NET INCOME: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
A Actual Net Income CAGR:1Y: 57.67%2Y: 4.91%5Y: 9.43%10Y: 14.06%
A - EBITDA: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
A Actual EBITDA CAGR:1Y: 38.12%2Y: 7.09%5Y: 6.21%10Y: 9.65%

Ratios, Profit Margins & Return on Capital:

A - Net Profit Margin
7-Day FREE Trial Get Full Access Now!
A Net Profit Margin CAGR:1Y: 43.29%2Y: -2.88%5Y: 5.46%10Y: 7.54%
A - Gross Profit Margin
7-Day FREE Trial Get Full Access Now!
A Gross Profit Margin CAGR:1Y: 5.91%2Y: 0.52%5Y: 0.52%10Y: 0.56%
A - Price to Earnings
7-Day FREE Trial Get Full Access Now!
A - Price To Sales Ratio
7-Day FREE Trial Get Full Access Now!
A - Return on Capital Employed
7-Day FREE Trial Get Full Access Now!
A - Return on Invested Capital
7-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

A Dividends Info:

Annual Dividend: $1.02
Forward Yield: 0.74%
Ex-Dividend Date: 2026-06-30
Lifetime Dividends / Share: $10.97

A Dividend History: Dates, Payments & Yield list

Below is a schedule of all A dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
06/30/202607/22/2026$0.2550.76%0.76%$133.46
03/31/202604/22/2026$0.2550.88%0.85%$120.47
01/06/202601/28/2026$0.2550.68%0.76%$133.87
09/30/202510/22/2025$0.2480.77%0.68%$145.87
07/01/202507/23/2025$0.2480.81%0.83%$119.47
04/01/202504/23/2025$0.2480.85%0.94%$105.00
12/31/202401/22/2025$0.2480.71%0.65%$152.60
10/01/202410/23/2024$0.2360.64%0.71%$133.03
07/02/202407/24/2024$0.2360.74%0.7%$134.16
04/01/202404/24/2024$0.2360.63%0.69%$137.49
12/29/202301/24/2024$0.2360.66%0.73%$129.78
10/02/202310/25/2023$0.2250.81%0.87%$103.40
06/30/202307/26/2023$0.2250.74%0.7%$128.47
04/03/202304/26/2023$0.2250.48%0.68%$133.12
12/30/202201/25/2023$0.2250.57%0.58%$155.76
10/03/202210/26/2022$0.2100.66%0.61%$137.69
07/01/202207/27/2022$0.2100.69%0.66%$127.71
04/04/202204/27/2022$0.2100.6%0.71%$117.68
01/03/202201/26/2022$0.2100.51%0.63%$133.51
10/04/202110/27/2021$0.1940.51%0.5%$155.26
07/02/202107/28/2021$0.1940.51%0.51%$151.46
04/05/202104/28/2021$0.1940.58%0.58%$134.80
01/04/202101/27/2021$0.1940.62%0.65%$118.80
10/05/202010/28/2020$0.1800.7%0.71%$101.66
06/29/202007/22/2020$0.1800.81%0.75%$96.35
03/30/202004/22/2020$0.1800.95%0.96%$75.17
12/30/201901/22/2020$0.1800.79%0.8%$90.13
09/30/201910/23/2019$0.1640.86%0.87%$74.98
07/01/201907/24/2019$0.1640.85%0.94%$69.58
04/01/201904/24/2019$0.1640.77%0.87%$75.79
12/28/201801/23/2019$0.1640.93%0.92%$71.65
10/01/201810/24/2018$0.1490.84%0.97%$61.13
07/02/201807/25/2018$0.1490.94%0.9%$65.96
04/02/201804/25/2018$0.1490.87%0.91%$65.80
12/29/201701/24/2018$0.1490.81%0.81%$73.58
10/02/201710/25/2017$0.1320.81%0.78%$67.39
06/29/201707/26/2017$0.1320.87%0.88%$59.72
03/31/201704/26/2017$0.1320.93%0.96%$54.83
12/29/201601/25/2017$0.1321.05%1.09%$48.41
09/30/201610/26/2016$0.1150.98%1.06%$43.37
06/30/201607/27/2016$0.1151%0.97%$47.26
04/01/201604/27/2016$0.1151.07%1.11%$41.58
12/31/201501/27/2016$0.1150.99%1.24%$37.05
09/25/201510/21/2015$0.1001.16%1.11%$35.90
06/26/201507/22/2015$0.1000.99%0.99%$40.33
03/27/201504/22/2015$0.1000.95%0.94%$42.71
01/02/201501/28/2015$0.1000.94%1.05%$38.00
09/26/201410/22/2014$0.0940.93%1%$37.95
06/27/201407/23/2014$0.0940.9%0.92%$41.11
04/09/201404/23/2014$0.0940.91%0.96%$39.35
12/27/201301/22/2014$0.0940.86%0.87%$43.58
09/27/201310/23/2013$0.0860.89%0.95%$36.23
06/28/201307/24/2013$0.0861.03%1.03%$33.45
03/28/201304/24/2013$0.0861%1.12%$30.65
12/27/201201/23/2013$0.0720.98%0.9%$31.69
09/28/201210/24/2012$0.0720.78%1.12%$25.64
06/29/201207/25/2012$0.0720.51%1.11%$25.85
03/30/201204/25/2012$0.0720.22%0.97%$29.46
11/01/200611/03/2006$1.4716.04%24.98%$23.56

Projected Future Returns & Dividends for A

Based on past 10-year performance, here are A growth metrics:

Share price CAGR of +11.12%
Dividend CAGR of +8.3%

Using A CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

A (DRIP)A - No DRIP
Current Price$137.45$137.45
Start Shares72.7572.75
Start Value$10,000$10,000
  
After 10 years:
Final Share Count77.7372.75
Dividends Payment$0.57$0.57
Annual Dividends$176$165
Yield on cost1.76%1.65%
Share Price$394.66$394.66
Total Dividends$1,133$1,091
Final Value$30,679$29,804

Estimated Future Value + Dividends - A

NOTE: Above numbers are our estimate based on A's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

[lev_ptables no_sale]

Company Info

Agilent Technologies, Inc. (A) had its IPO on 1999-11-18, and is trader on NYSE stock exchange.

Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.

A website: https://www.agilent.com


Get Full Access to All Reports with DRIPCalc PRO

[lev_ptables no_sale]